Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
PHARMARON Surges 8%+ at Midday as Nomura Raises TP
Recommend 4 Positive 5 Negative 2 |
||||
|
||||
|
PHARMARON (03759.HK) opened 2.87% higher today and once peaked at HKD20.64. It ended the midday at HKD20.44, up 8.61%, with a trading volume of 9.5382 million shares, involving HKD190 million. Nomura's report said PHARMARON's 4Q25 results met expectations, with revenue and earnings growing by 16% and 41% YoY, respectively. During the earnings call, PHARMARON's management projected that revenue in 2026 will grow by 12-18% YoY, which aligned with market expectations at the midpoint but exceeded Nomura's previous estimates. This growth guidance has factored in exchange rate effects; Otherwise, actual growth would be 3 ppts higher. Nomura has kept a Buy rating on PHARMARON and increased its target price from HKD26.63 to HKD27.33. This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
